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Summary
The purpose of this study was to investigate the rela-
tionship between the extent of hyperenhancement and
left ventricle maximal wall thickness (mWT) detected by
LGE CMR and clinical events of nonsustained ventricu-
lar tachycardia (NSVT), implantation of cardioverter
defibrillator (ICD) or diastolic heart failure in HCM
patients that underwent LGE CMR.
Background
Late gadolinium enhancement cardiac magnetic reso-
nance (LGE CMR) imaging has been used to detect
myocardial hypertrophy and scar/fibrosis in Hyper-
trophic cardiomyopathy (HCM) patients. The presence
of hyperenhancement has been associated with progres-
sive ventricular dilation, ventricular arrhythmias and
clinical risk factors for sudden cardiac death.
Methods
Under IRB approved protocol a total of 82 HCM
patients underwent LGE CMR images using a 2D PSIR
TurboFLASH protocol after administration of 0.2 mmol
of gadopentetate dimeglumine per kilogram of body
weight. The presence of LGE was assessed using auto-
mated software: percentage of scar and maximal wall
thickness were calculated. Percentage of scar was com-
pared between patients with mWT <2.5 cm and ≥2.5cm
The mean values of percentage scar and mean maximal
wall thickness between patients with/ without clinical
events (presence of NSVT, placement of ICD or devel-
opment of diastolic heart failure) were compared.
Results
Scar was detected in 74.5 % patients and clinical events
were present in 54 (%) patients. Only one patient with-
out scar had NSVT and had ICD implanted. There was
a significant difference between mWT in patients with
scar (2.0 cm) and no scar (1.5 cm) p =0.002. Scar % and
mean mWT were significant higher in patients with
positive clinical events(Table 1.There was no significant
difference between % of scar in patients with risk factors
when compared the mWT ≥2.5cm and <2.5 cm. How-
ever patients with positive clinical events with
mWT≥2.0cm presented higher scar % compared to
patients with positive clinical events with mWT<2.0cm
(Table2).
Conclusions
In conclusion, HCM patients with a mWT above 2.5 cm
maybe at increased risk of events regardless of the
amount of myocardial scar.
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Table 1 Relationship between % SCAR/ mean wall
thickness in HCM and clinical events
Clinical events
+
Clinical events
-
p
value
%SCAR 30.49 17.26 0.001
Mean Maximal wall thickness
(cm)
2.087 1.723 0.006
Table 2 Comparison between Scar % and clinical events
with mWT of 2.0 or 2.5 cm
Clinical events + p value
mWT<2.0cm mWT≥2.0cm
% SCAR 25.21 36.16 0.006
mWT <2.5cm mWT≥2.5cm
% SCAR 32.38 34.66 0.71
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